TLDR Oral minoxidil may be a better treatment for hair loss than topical minoxidil.
Oral minoxidil emerged as a potential treatment for androgenetic alopecia (AGA), addressing limitations of topical minoxidil such as lack of efficacy, poor compliance, and adverse effects like irritant dermatitis. AGA, characterized by progressive follicular miniaturization, manifests as male pattern hair loss (MPHL) in men and female pattern hair loss (FPHL) in women. Oral minoxidil aimed to improve treatment response without increasing the dose, offering a promising alternative for patients experiencing barriers with topical application.
6 citations,
July 2018 in “PubMed” The treatment is safe and very effective for hair growth in Asian men with minimal side effects.
1 citations,
October 2022 in “PubMed” Patients generally have positive attitudes towards using topical Minoxidil for hair loss treatment.
1 citations,
August 2022 in “JAAD case reports” Tofacitinib and oral minoxidil may help treat Sisaipho alopecia areata.
1 citations,
March 2021 in “CRC Press eBooks” Oral minoxidil may be a better treatment for hair loss than topical minoxidil.
3 citations,
May 2020 in “Journal of The Korean Medical Association” Minoxidil and finasteride are effective for treating hair loss, with dutasteride showing potential but with side effects.
Baldness is often hereditary and linked to male hormones, becoming noticeable when half the hair is lost.
July 2013 in “DeckerMed Medicine” The document's conclusion cannot be provided because the document is not readable or understandable.
8 citations,
May 1987 in “Journal of The American Academy of Dermatology” UV light does not significantly affect minoxidil's ability to treat male pattern baldness.
